Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

NCT04852081 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage IV

Interventions

DRUG: Palbociclib
DRUG: Ribociclib
DRUG: Abemaciclib
DRUG: Letrozole
DRUG: Anastrozole
DRUG: Tamoxifen
DRUG: Fulvestrant
DRUG: Exemestane
DRUG: Alpelisib

Sponsor

Blokhin's Russian Cancer Research Center